Forbes November 18, 2025
Bruce Japsen

UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.

Gottlieb, who is 53 years old, served as FDA commissioner from 2017 to 2019 during the first Trump administration and also held key roles at the Centers for Medicare & Medicaid Services during the administration of George W. Bush when the Medicare part D drug benefit was implemented.

Adding Gottlieb to UnitedHealth’s board comes at a critical time for health insurance companies as they navigate rising costs, particularly in their business administering Medicare Advantage plans. Meanwhile, health insurers are increasingly faced with the launch of new and more expensive drugs derived by biotechnology like GLP-1 drugs for weight loss.

...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Payer
H.R.1 Threatens The Stability Of Medicaid Managed Care
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
How To Keep Competition Alive In Medicaid Managed Care Markets
Fortifying Medicaid Managed Care for Postpartum Enrollees: The Clearest Path to Improving Maternal Health
UnitedHealth Group's earnings reflect industry-wide pressure

Share Article